Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

Summary: Cell-based immunotherapy has become the new-generation cancer medicine, and “off-the-shelf” cell products that can be manufactured at large scale and distributed readily to treat patients are necessary. Invariant natural killer T (iNKT) cells are ideal cell carriers for developing allogenei...

Descripció completa

Dades bibliogràfiques

Autors principals:	Yan-Ruide Li, Yang Zhou, Yu Jeong Kim, Yanni Zhu, Feiyang Ma, Jiaji Yu, Yu-Chen Wang, Xianhui Chen, Zhe Li, Samuel Zeng, Xi Wang, Derek Lee, Josh Ku, Tasha Tsao, Christian Hardoy, Jie Huang, Donghui Cheng, Amélie Montel-Hagen, Christopher S. Seet, Gay M. Crooks, Sarah M. Larson, Joshua P. Sasine, Xiaoyan Wang, Matteo Pellegrini, Antoni Ribas, Donald B. Kohn, Owen Witte, Pin Wang, Lili Yang
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2021-11-01
Col·lecció:	Cell Reports Medicine
Matèries:	hematopoietic stem cell invariant natural killer T cells cancer immunotherapy allogeneic off-the-shelf cell therapy chimeric antigen receptor allogeneic HSC-engineered iNKT cells
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2666379121003177
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!